Patent · US Active

Modulators

US9944698B2 · kind B2 · utility

3Cited by
41References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 26, 2014
Grant dateApr 17, 2018
Priority date—
Expiry dateJan 18, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that modulate insulin receptor signaling are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.